FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Topical topics
Amino Acid
Emulsifiers
Homogeneous
Crystallin
Prophylaxis
Peripheral Vascular Disease
Vascular Disease
Circulation
Antimicrobial
Nitric Oxide
Spectrometry
Mass Spectrometry
Drug Resistance
Mitochondria
Ophthalmic

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Topical patents



      
           
This page is updated frequently with new Topical-related patent applications. Subscribe to the Topical RSS feed to automatically get the update: related Topical RSS feeds. RSS updates for this page: Topical RSS RSS


Date/App# patent app List of recent Topical-related patents
07/17/14
20140200487
 Portable electronic therapy device and the method thereof patent thumbnailPortable electronic therapy device and the method thereof
The present disclosure relates to an electronic therapy device including automatic controlled application of energies along with feedback control using sensors for improved synergistic effects and further the device is configured to be used for longer periods of time for improved and optimal therapeutic results without causing any adverse effects, the device can be used for pain management, healing, fitness, cosmetic and topical delivery related applications and a method for performing electronic therapy using the said portable electronic device.. .
07/17/14
20140200274
 Methods and compositions for treating raynaud's disease patent thumbnailMethods and compositions for treating raynaud's disease
In various embodiments, methods and compositions for treating raynaud's disease and raynaud's phenomenon are provided. Topical administration of a semisolid composition comprising a prostaglandin e1 compound provides the desired relief of the raynaud's disease or raynaud's phenomenon without the possible complications of systemic administration.
07/17/14
20140200268
 Composition and method for treating dry eye syndrome patent thumbnailComposition and method for treating dry eye syndrome
The present invention provides for compositions, medicaments, and methods for treating or alleviating the symptoms of dry eye syndrome or chronic dry eye. More specifically, the present embodiments provide for medicaments consisting of tocopherol or tocotrienol eyedrops.
07/17/14
20140200203
 Topical pharmaceutical compositions patent thumbnailTopical pharmaceutical compositions
Topical pharmaceutical compositions are described comprising, based on the total weight of the composition: a) 0.01 to 0.2 wt. % of mometasone furoate, b) 5 to 18 wt.
07/17/14
20140199721
 Reconstructed scalp model and process for screening active molecules patent thumbnailReconstructed scalp model and process for screening active molecules
The invention relates to a reconstructed scalp model, to the process for preparing it and to its use for evaluating the effect of cosmetic, pharmaceutical or dermatological topical products. The reconstructed scalp according to the invention may also be used for the preparation of the grafts intended for treating cutaneous scalp disorders..
07/17/14
20140199716
 Isotopic recoding for targeted tandem mass spectrometry patent thumbnailIsotopic recoding for targeted tandem mass spectrometry
Aspects of the present disclosure include methods for detecting a low abundance protein and methods for identifying a site of n-glycosylation on a protein. In practicing methods according to certain embodiments, a eukaryotic cell is contacted with an isotopic labeling composition and isotopically labeled n-glycosylated peptides obtained from the eukaryotic cell are assessed by liquid chromatography-tandem mass spectrometry.
07/17/14
20140199413
 Melatonin and an antimicrobial or antibacterial agent for the treatment of acne patent thumbnailMelatonin and an antimicrobial or antibacterial agent for the treatment of acne
The invention relates to formulations for topical use comprising an antiseborrheic agent and an antimicrobial and/or antibacterial agent for the treatment of inflammatory dermatoses. In particular said formulations comprise melatonin and an antimicrobial or antibacterial agent, can be used in the pharmaceutical, cosmetic/cosmeceutical or dermatological field and are particularly suitable for the treatment of acne and of the clinical symptoms associated thereto..
07/17/14
20140199400
 Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same patent thumbnailActive agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
Uniform, rigid, spherical nanoporous calcium phosphate particles that define an internal space and an amount of active agent present in the internal space are provided. Also provided are topical delivery compositions that include the active agent loaded particles, as well as methods of making the particles and topical compositions.
07/17/14
20140199367
 Topical transdermal method for delivering nutrients through the skin for expeditied wound healing and skin rejuvenation patent thumbnailTopical transdermal method for delivering nutrients through the skin for expeditied wound healing and skin rejuvenation
This delivery system bypasses digestion and dilution. Key is a lipophilic carrier with nuclear and mitochondrial ligands that rapidly penetrate and permeate all membranes and truncates the inflammatory site quickly manifesting curation.
07/17/14
20140199350
 Chimeric topical vaccine for haemophilus influenzae-induced disease patent thumbnailChimeric topical vaccine for haemophilus influenzae-induced disease
Provided are delivery systems for topically administering a chimeric protein including the nthi twitching pilus major subunit protein (pila) presenting a portion of the nthi omp p5 protein. Also provided are methods for eliciting a response by administrating the delivery systems to a subject..
07/10/14
20140194526
Stabilized compositions of volatile alkylating agents and methods of using thereof
A composition and method for treatment of cancer. The composition for treating a skin disorder, comprising: a nitrogen mustard or an hx salt of the nitrogen mustard, wherein the nitrogen mustard or the hx salt of the nitrogen mustard is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol, wherein the non-aqueous vehicle or carrier that does not include petrolatum or ethanol does not include petrolatum or ethanol.
07/10/14
20140194514
Topical formulations
Topical treatments for neuropathy are described. The treatments include topical formulations of nmda antagonists and one additional active ingredient.
07/10/14
20140194475
Animal parasite-control method using insect growth regulators
Methods and formulations for treating animal ectoparasites, effective against parasites such as fleas and ticks are provided. The methods comprise topically co-administering a non-mobile insect growth regulator and a mobile insect growth regulator to the animal.
07/10/14
20140194450
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide f2 alpha agonists
The present invention is directed to compositions and methods for the treatment of post-chemotherapeutic hypotrichosis. More specifically, the present invention is directed to the use of compositions comprising bimatoprost for the treatment of post-chemotherapeutic hypotrichosis which may be applied before, during and after receiving chemotherapeutic treatment..
07/10/14
20140194375
Topical antibiotic composition for the prevention of lyme disease
The invention relates to topical pharmaceutical compositions and methods related to borrelia burgdorferi toxins, in particular, the present invention provides compositions and methods for the treatment of infections caused by borrelia burgdorferi and in particular for the prevention of lyme disease.. .
07/10/14
20140193532
Complementary personal lubricant compositions
This invention relates to novel compositions and methods of use by which the compositions of this invention are applied topically to one or more body parts of at least two individuals who bring said body parts into contact with the other individual and, when said body parts come into contact with each other, permit the formulations to interact and thereby achieve an unexpected sensation to each individual.. .
07/10/14
20140193502
Foam prepared from nanoemulsions and uses
The present invention provides a foamable composition for administration to the skin, body surface, body cavity or mucosal surface, e.g., the mucosa of the nose, mouth, eye, ear, respiratory system, vagina or rectum, and methods of using such a composition to treat, alleviate, or prevent a disorder of the skin, body cavity, or mucosal surface. The foamable oil in water nano emulsion composition includes: (a) a nano oil globule system, comprising substantially of sub-micron oil globules; (b) about 0.1% to about 5% by weight of at least one stabilizing agent selected from (i) a non-ionic surfactant, (ii) an ionic surfactant, or (iii) a polymeric agent; and (c) a liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition, water and optional ingredients.
07/10/14
20140193480
Topical anti-inflammatory compositions and uses thereof
Disclosed are pharmaceutical compositions and topical formulations thereof that include multiple, phytochemically-active, nutraceutical compounds, and that possess potent anti-inflammatory and extracellular matrix-stabilizing properties both in vitro and in vivo. Also disclosed are prophylactic and therapeutic methods, as well as dosing regimens and medicaments for use in preventing chronic disease, for treating acute or long-term inflammatory-mediated conditions in affected or at-risk subjects, and for stabilizing one or more components of the mammalian extracellular matrix..
07/10/14
20140193349
Use of cannabinoid compounds for stimulating melanogenesis
It being understood that, when r3 and r4 together form an oxo group with the carbon atom which bears them and x represents an oxygen atom, then r1 cannot represent a hydroxymethyl group, as an agent for coloring keratin materials. It also relates to one of these specific cannabinoid compounds for use thereof in the treatment of vitiligo or pityriasis versicolor, to nontherapeutic cosmetic processes for coloring the skin or for treating canities, comprising the topical application to the skin and/or head hair, or the oral administration, of a composition comprising, in a physiologically acceptable medium, one of these cannabinoid compounds, and to a process for selecting an active agent which promotes the pigmentation of keratin materials..
07/10/14
20140193347
Lipid depot formulations
Wherein at least one bioactive agent is dissolved or dispersed in the low viscosity mixture and wherein the pre-formulation forms, or is capable of forming, at least one liquid crystalline phase structure upon contact with an aqueous fluid. The preformulations are suitable for generating parenteral, non-parenteral and topical depot compositions for sustained release of active agents.
07/10/14
20140193346
Health supplement
Herbal composition and method for the treatment of inflammatory pain associated with tendonitis, bursitis, arthritis, carpal tunnel syndrome, tennis elbow, plantar fasciitis, sports injuries, lower back pain and overexertion, gingivitis and muscle aches, that is compliant with hpus monographs and/or over-the-counter fda topical analgesic monograph requirements.. .
07/10/14
20140193298
Antimicrobial compositions and methods of use
In one aspect, compositions provide antimicrobial therapy as topical disinfectants. Particularly, one aspect relates to an alcohol containing antimicrobial composition that includes at least one paraben, a redox compound and an organic acid at a concentration of from about 1.5 percent to about 10 percent by weight, based on the total weight of the composition.
07/03/14
20140187969
Drop generating device
A method of delivering safe, suitable, and repeatable dosages to a subject for topical, oral, nasal, or pulmonary use and a device for droplet ejection includes a fluid delivery system capable of delivering a defined volume of the fluid in the form of droplets having properties that afford adequate and repeatable high percentage deposition upon application. The method and device include a housing, a reservoir disposed within the housing for receiving a volume of fluid, an ejector mechanism configured to eject a stream of droplets having an average ejected droplet diameter greater than 15 microns, the stream of droplets having low entrained airflow such that the stream of droplets deposit on the eye of the subject during use..
07/03/14
20140187810
Stabilized compositions of alkylating agents and methods of using same
Provided are stable compositions comprising alkylating agents, including nitrogen mustards, that are suitable for topical use, and methods for treating skin disorders comprising topically administering the compositions.. .
07/03/14
20140187642
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide f2 alpha agonists
The present invention is directed to compositions and methods for the treatment of post-chemotherapeutic hypotrichosis. More specifically, the present invention is directed to the use of compositions comprising bimatoprost for the treatment of post-chemotherapeutic hypotrichosis which may be applied before, during and after receiving chemotherapeutic treatment..
07/03/14
20140187637
Tromethamine salt of bimatoprost acid in crystalline form, methods for preparation, and methods for use thereof
The present invention provides tromethamine salt of 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-hept-5-enoic acid in crystalline and amorphous form. This compound is may also be referred to as “tromethamine salt of bimatoprost acid.” the invention crystalline form is useful for solid ocular implant or topical formulations, utilized in the treatment of various ocular conditions, such as, for example, ocular hypertension..
07/03/14
20140187629
Use of bethanechol for treatment of xerostomia
A formulation for topical administration, comprises bethanechol and a penetration enhancer. The formulation is preferably used by being maintained in the buccal cavity for a period of time prior to being swallowed..
07/03/14
20140187578
Pharmaceutical topical compositions
The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream.. .
07/03/14
20140187575
Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
Pharmaceutical formulations and methods for the topical or transdermal delivery of 1isobutyl-1h-imidazo[4,5-c]-quinolin-4-amine, or 1-(2-methylpropyl)-1h-imidazo[4,5 c]quinolin-4-amine, i.e., imiquimod, to treat genital/perianal warts with shorter durations of therapy than currently prescribed for the commercially available for aldara® 5% imiquimod cream, as now approved by the u.s. Food & drug administration (“fda”), are disclosed and described.
07/03/14
20140187523
Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention..
07/03/14
20140187492
Single component fibrin hemostat
Clotgel is a single-component hemostatic agent designed for use as an adjunct or primary treatment in moderate intraoperative hemorrhage and in trauma. It can be applied topically to the wound either on the skin in a laparatomy or as non-invasive manner in surgical procedures.
07/03/14
20140187478
Peptide toxin formulation
Procedures are described which use solvents to increase the topical insecticidal activity of toxic insect peptides. These procedures comprise drying the peptides, if needed, followed by the addition of either: 1) a polar organic solvent, with or without water, to a dried peptide, or 2) the addition of polar aprotic solvent or other adjuvant to the dried peptide, followed by the addition of either: 1) a polar organic solvent, with or without water, (where a polar aprotic solvent is added first) or 2) a polar aprotic solvent or other adjuvant to the peptide polar organic solvent (where the polar organic solvent is added first), to the peptide formulation..
07/03/14
20140187475
Lantibiotic compositions and methods for preventing or treating mastitis
A composition suitable for application to the skin comprising at least one lantibiotic, an acidic external phase aqueous solution, at least one pharmaceutically acceptable internal phase carrier material, and a combination thereof. A method for preventing or treating mastitis, comprising administering to a human in need of such treatment a topical composition comprising a therapeutically-effective amount of at least one lantibiotic, an acidic aqueous solution, and at least one pharmaceutically acceptable carrier material..
07/03/14
20140186873
Synthesis and use of isotopically labeled macrocyclic compounds
Disclosed herein are isotopically labeled antifungal antibiotics and related compounds. Also disclosed are methods for synthesizing these isotopically labeled molecules and using the same to study the distribution of these compounds in the biosphere as well as the products formed by the breakdown of these isotopically labeled compounds..
07/03/14
20140186442
Topical minocycline compositions and methods of using the same
Topical minocycline compositions with reduced fluorescence are provided. In some instances, the compositions include an amount of a minocycline active agent associated with porous calcium particles.
07/03/14
20140186306
Novel ampk agonist compositions and methods of use
The invention relates to novel ampk agonist containing compositions that are adapted for localised use in treating inflammation and/or pain due to disease or injury in a human or animal. The novel compositions of the invention are useful in the treatment of a variety of conditions including osteoarthritis (oa), synovitis, tendonitis, desmitis; cystitis, osteitis and laminitis.
07/03/14
20140186279
Topical bioadhesive formulations
Wherein at least one bioactive agent is dissolved or dispersed in the low viscosity mixture and wherein the pre-formulation forms, or is capable of forming, at least one liquid crystalline phase structure upon contact with an aqueous fluid. The invention additionally relates to a method of delivery of an active agent comprising administration of a preformulation of the invention, a method of treatment comprising administration of a preformulation of the invention and the use of a preformulation of the invention in a method for the manufacture of a medicament..
07/03/14
20140186278
Anhydrous multiphase gel system
An anhydrous multiphase gel system consisting of an outer lipid matrix and an inner phase gelled by means of a polymer is described, which can be obtained by a) melting the lipid phase with the formation of a liquid lipid phase, b) mixing and homogenizing polymers or polymer blends capable of swelling with the formation of a polymer phase to be dispersed, c) combining the polymer phase with the liquid lipid phase and homogenizing the phases, and d) cold stirring the phase mixture until a solid gel-like mixed structure of the entire system is formed. The anhydrous multiphase gel system is particularly suitable for taking up difficulty soluble active substances in high concentration and for providing topical and transdermal applications.
06/26/14
20140180979
Interestingness recommendations in a computing advice facility
The present disclosure provides a recommendation to a user through a computer-based advice facility, comprising collecting topical information, wherein the collected topical information includes an interestingness aspect; filtering the collected topical information based on the interestingness aspect; determining an interestingness rating from the collected topical information, wherein the determining is through the computer-based advice facility; and providing a user with the recommendation related to the topical information based on the interestingness rating.. .
06/26/14
20140180227
Breathable interface system for topical reduced pressure
A reduced pressure tissue treatment system includes an applicator having an aperture, a first pad section, and a second pad section substantially covering the aperture and positioned substantially adjacent the first pad section. A fabric layer is located at least partially between the second pad section and the drape, and the fabric layer includes a woven or non-woven fabric made from a fiber material.
06/26/14
20140179745
Topical ophthalmological pharmaceutical composition containing regorafenib
The present invention relates to topical ophthalmological pharmaceutical compositions containing regorafenib, a hydrate, solvate or pharmaceutically acceptable salt thereof or a polymorph thereof but without hydrophobic silica and its process of preparation and its use for treating ophthalmological disorders.. .
06/26/14
20140179739
Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
The invention relates to a method of treating attention deficit disorder (add) and attention deficit/hyperactivity disorder (adhd) and compositions for topical application of methylphenidate comprising methylphenidate in a flexible, finite system wherein the methylphenidate is present in an amount sufficient to achieve substantially zero order kinetics for delivery to the skin or mucosa of a patient in need thereof over a period of time at least 10 hours.. .
06/26/14
20140179649
Compositions and methods for the treatment of skin diseases
Provided herein are chemical matrices, compositions, and methods for the treatment of skin diseases and disorders in an individual. Said chemical matrices and compositions comprise an alcohol selected from ethanol, isopropanol or n-propanol, at least one excipient, and, a corticosteroid, wherein the alcohol is distributed within the chemical matrix as a microbubble and the corticosteroid is present in less than the standardized topical corticosteroid concentration.
06/26/14
20140179643
Plod-2 stimulators and their use in the treatment of skin
Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ a composition comprising an effective amount of n-acetyl-tyrosinamide and an effective amount of a retinoid, in a cosmetically acceptable vehicle, for topical application to the skin for a time sufficient to improve the appearance of said skin.. .
06/26/14
20140179640
Topical compositions for the treatment of dermatological disorders
The present invention relates to pharmaceutical compositions and methods useful for the treatment of dermatological disorders, and in particular acne vulgaris and skin pigmentation disorders. Pharmaceutical compositions comprising one or more arginine, salicylic acid and/or azelaic acid that are useful for the treatment of dermatological diseases and the symptoms and underlying causes of such dermatological diseases are also disclosed..
06/26/14
20140178496
Endospore compositions and uses thereof
Provided herein in some embodiments is a composition that comprises (a) a nanoscale particle(s) or a microscale particle(s); and (b) a film-forming polymer. Also provided herein is a method for an immediate and sustained released formulation suitable for topical administration or administration to surfaces.
06/26/14
20140178487
Camel hump oil - based herbal compositions and method of making the same
The embodiments herein provide camel hump oil based herbal compositions and methods for preparing these compositions for treatment of a plurality of diseases such as dermatological conditions, musculoskeletal conditions and hair conditions. The embodiments herein also provide a method of extraction of camel hump oil from a camel hump and a method of de-odorizing the extracted camel hump.
06/26/14
20140178446
Hemostatic agent for topical and internal use
This invention relates to deployable hemostatic materials comprising chitosan fibers. The hemostatic materials are suitable for use in sealing or controlling active bleeding from artery and vein lacerations and punctures, and for controlling oozing from tissue..
06/26/14
20140178318
Novel compounds
Methods of making polyglycerol based uv-filters, topical compositions comprising such polyglycerol based uv-filters and the use of such novel polyglycerol based uv-filters to enhance the solubility of butyl methoxydibenzoylmethane or bis-ethylhexyloxyphenol methoxyphenyl triazine in cosmetic oils are provided.. .
06/26/14
20140178316
Skin treatments containing pyrroloquinoline quinone (pqq) esters and methods of preparation and use thereof
The present invention relates to cosmetic or dermatological compositions containing pqq or its esters, methods of treating or promoting skin changes by topical application of these compositions, and methods of synthesis of pqq esters. The pqq ester-containing compositions of the present invention are unexpectedly effective in treating skin, particularly with respect to skin tolerance.
06/26/14
20140178315
Topical compositions comprising ionic fluids
The present invention relates to anhydrous or essentially anhydrous compositions intended for topical application on keratinaceous surfaces, wherein the composition includes a) an ionic fluid and b) a thickener. The compositions are advantageous for allowing the ionic fluid to act as the continuous phase of a topical formulation..
06/19/14
20140172837
Topical activity monitor and identity collector system and method
A method for identifying respective networked devices in a social communications network, which networked devices communicate messages relevant to an article. The messages may include posts, shares, likes, votes, ranks, and other comments.
06/19/14
20140171399
Topical skin care composition
A cream base for the topical application of skin care therapeutics and a process for making the cream base. In one embodiment, the therapeutic is tretinoin, hydroquinone and fluocinolone acetonide for the treatment of hyperpigmented skin conditions, such as melasma..
06/19/14
20140170251
Topical formulations for increasing the dermal concentration of hyaluronic acid
Described herein are methods and compositions for increasing dermal concentrations of glycosaminoglycans (gag), including hyaluronic acid. Exemplary methods involve a one-step protocol and a three-step protocol.
06/19/14
20140170249
Botanical formulation derived from birch bark
A formulation and method of mitigation of symptoms of patients suffering from a neurocutaneous pain syndrome by topical application of the formulation. The formulation is obtained by steeping the bark of a tree from the genus betula in an aqueous acidified solution and then subsequent filtering, packaging and sterilization..
06/19/14
20140170246
Topical composition
A topical composition having at least one active agent selected from a depilatory agent(s), an agent(s) for preventing or reducing the growth or re-growth of hair and an agent(s) for preventing or reducing in-growing hair, and a gas, wherein the at least one active agent and gas are dispersed in a cosmetically acceptable medium.. .
06/19/14
20140170231
Pain relief compositions and methods
An analgesic composition useful for soothing body aches, pains and sores. The analgesic composition can include methyl salicylate, turpentine oil, camphor oil, sassafras oil, beta carotene, emu oil, oleoresin capsicum, chlorophyllin, and mustard oil.
06/19/14
20140170088
Barium zirconium oxide (bazro3.baco3) nanoparticles
The present disclosure provides nanoparticles of barium zirconium oxide (bazro3.baco3) and a process for preparation thereof. The present disclosure further provides a coating formulation that chiefly comprises the bazro3.baco3 nanoparticles along with its method of preparation.
06/19/14
20140170080
Antioxidant topical compositions
The present invention relates to topical aerosol compositions comprising l-ascorbic acid. The compositions comprise (a) l-ascorbic acid, or a pharmaceutically acceptable salt or ester thereof, (b) water, (c) lower alcohol and (d) an aerosol propellant.
06/12/14
20140164304
Method of answering questions and scoring answers using structured knowledge mined from a corpus of data
In a method of answering questions and scoring answers, a title and at least one topical field are identified for a document. A field name and field content associated with the topical field is identified, and a title-oriented document is created by combining the title, the field name, and the field content associated with the topical field.
06/12/14
20140164303
Method of answering questions and scoring answers using structured knowledge mined from a corpus of data
In a method of answering questions and scoring answers, a title and at least one topical field are identified for a document. A field name and field content associated with the topical field is identified, and a title-oriented document is created by combining the title, the field name, and the field content associated with the topical field.
06/12/14
20140163443
Massaging topical oils applicator
A massaging applicator device for applying topical oils to an individual, such as a person or creature, and methods of applying topical oils are disclosed. Some embodiments of an exemplary massaging applicator device may include an applicator body containing a vibration assembly.
06/12/14
20140163106
Protection against skin diseases by aurin tricarboxylic acid and its derivatives
This invention describes a method of preventing and treating inflammatory skin diseases by topical application of aurin tricarboxylic acid and its derivatives. Such diseases are characterized by immune attack, especially involving aberrant complement activation.
06/12/14
20140163105
Topical preparation for pain relief
A composition for pain relief including synergistically effective amounts of an amino benzoate local anesthetic, methylsulfonylmethane (msm), and ethoxydiglycol. A method of treating pain, by applying the composition to skin in an area of pain, and blocking nerve signals.
06/12/14
20140163098
Compositions and methods for reducing body fat
The present invention relates to compositions, such as bimatoprost, latanoprost and travoprost, and methods to reduce fat in the body of an individual, for example, by topical administration, injection, and/or implantation of such compositions.. .
06/12/14
20140162992
Topical application of dihydrotestosterone for promoting hair growth containing formulations
The present invention relates to the composition and method of use for the topical application of the potent androgen hormone dihydrotestosterone (dht), used alone or in fixed combination with other hair growth medications; including other androgens, bimatoprost, other prostamides, prostaglandins, minoxidil or apocrine hair growth factors to promote and enhance hair growth of terminal mustache hair, beard hair, also chest hair, and other male androgen sensitive or dependent hair growth in humans or animals.. .
06/12/14
20140162982
Topical compositions for use in the prevention and/or treatment of dermatitis
The present invention relates to the use of topical compositions containing bromociclen for the prevention and/or treatment of various types of dermatitis, in particular eczema and psoriasis.. .
06/12/14
20140162959
Suspension type topical formulations comprising cyclic depdipeptide
And to methods for manufacturing such compositions.. .
06/12/14
20140162291
In vitro method using human skin for evaluating the influence of abc transporters
An in vitro method is described that uses full-thickness human skin for evaluating the influence of abc transporters (such as mdr1, mrp1, mrp2 or bcrp) on the absorption and distribution of topically applied medicinal substances.. .
06/12/14
20140161909
Medemia nobilis extracts and methods of use
The present invention describes methods for improving the appearance of skin, particularly, treating, ameliorating, preventing, delaying, and/or improving one or more signs of aging, by topically applying compositions comprising an extract of medemia nobilis.. .
06/12/14
20140161903
Compositions for the treatment and prevention of eyelid swelling
The invention features topical formulations comprising an osmotically active agent and/or a vasoconstrictor and/or an astringent agent for the treatment and prevention of eyelid swelling, and methods of use thereof.. .
06/12/14
20140161889
Transdermal formulation containing cox inhibitors
Disclosed are gel compositions suitable for the topical administration of an active compound having poor solubility and skin penetration, for example, of a cox-2 inhibitor compounds, processes of preparation thereof and methods of use thereof for the treatment of indications treatable by the active compound.. .
06/12/14
20140161868
Transdermal delivery system kit
A transdermal delivery kit that enhances the efficacy of a topical drug includes at least one drug dispensing device, a lipophilic base, a hydrophilic base, a lipid-soluble active ingredient, a water-soluble active ingredient, a first container for mixing the lipophilic base with the lipid-soluble active ingredient to form a first compound, a second container for mixing the hydrophilic base with the water-soluble active ingredient to form a second compound, a mixing member, and instructions for compounding the lipophilic base with the lipid-soluble active ingredient to form the first compound, compounding the hydrophilic base with the water-soluble active ingredient to form the second compound, and mixing the first compound and the second compound to form a transdermal pharmaceutical delivery system capable of delivering a drug to the dermal layer of the skin.. .
06/12/14
20140161867
Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
This invention relates to a convenient and safe product and method of applying glycopyrrolate topically in order to reduce excessive sweating in localized areas for those who suffer from this condition. This invention also relates to combining oral and topical delivery of glycopyrrolate to reduce excessive sweating and minimize side effects.
06/12/14
20140161866
Structures and methods for delivering topical compositions
A system for topically administering a chemical agent to a human body. The chemical agent may be mixed with a carrier and the form a tangible application device.
06/12/14
20140161746
Topical compositions and methods of manufacturing them in specifically treated steel vessels
Stable hydroquinone compositions that are useful for skin care and can have a shelf life of up to three years are prepared in a tank made from a material that does not release metallic ions into the composition.. .


Popular terms: [SEARCH]

Topical topics: Amino Acid, Emulsifiers, Homogeneous, Crystallin, Prophylaxis, Peripheral Vascular Disease, Vascular Disease, Circulation, Antimicrobial, Nitric Oxide, Spectrometry, Mass Spectrometry, Drug Resistance, Mitochondria, Ophthalmic

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Topical for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Topical with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.5271

3265

0 - 1 - 76